The Size of the North America Organ Preservation Market was valued at USD 95.77 million in 2022 and estimated to grow at a CAGR of 9%, to reach USD 147.35 million by 2027 during the forecast period 2022 to 2027.
Rising number of cases of organ failure in North America, demand is on the rise. In addition, the increasing incidence of organ failure and the growing amount of organ transplant surgeries in North America are driving the market forward.
Over the previous three decades, one of the main factors in Cardiovascular Diseases has become one of the most common causes of mortality and morbidity. The most common cardiovascular diseases in North America are coronary artery disease, arrhythmias, peripheral vascular disease, heart failure, and congenital heart defects.
The rising number of cases of renal failure and chronic kidney disease is likely to drive market expansion. In addition, the increased prevalence of chronic liver disease and cirrhosis in North America is expected to fuel market expansion.
The major growth factors for the organ preservation market are increasing incidences of organ failures occurring worldwide due to the high growth of the senior population, as well as various regional authorities providing favorable regulations, organizing initiatives, and creating awareness programs to increase the volume of organ donations and organ transplantation procedures in North America.
Large-scale costs associated with organ transplantation restrict consumers to a smaller consumer base in North America. In contrast, a lack of suitable donors and alternative modes of organ transplantation available, such as developing organs using stem cell procedures, are expected to limit the market's growth in the forecasted period.
The increase in senior citizens in North America will also drive market growth for organ preservation solutions, as the risk of organ failure is higher in this age group.
This research report on the North America Organ Preservation Market has been segmented and sub-segmented into the following categories.
By Preservation Solution:
By Transportation Technique:
By Organ Type:
By Country:
Geographically, North America dominated the Organ Preservation Market with a 39 percent share. A significant driver driving the organ preservation market during the forecast period is the rising usage of improved medical technologies and increased development by firms involved in organ preservation.
North America led the market in 2019 and is projected to do this shortly. The rising adoption of innovative healthcare technology, the high prevalence of chronic renal disease and heart failure, improved reimbursement rules, and more investments in enhancing healthcare infrastructure are all driving the industry forward.
Individual market affecting factors and changes in market regulation in the United States organ preservation market and Canada organ preservation market are also covered in the national portion of the organ preservation market study, which impacts the market's current and future trends.
KEY MARKET PLAYERS
Some of the Promising Companies dominating the North America Organ Preservation Market Profiled in the Report are Essential Pharmaceuticals (U.S.), Dr Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.).,
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technique
5.1.1 Introduction
5.1.2 Static Cold Storage (SCS) Technique
5.1.3 Hypothermic Machine Perfusion
5.1.4 Normothermic Machine Perfusion
5.1.5 Y-o-Y Growth Analysis, By Technique
5.1.6 Market Attractiveness Analysis, By Technique
5.1.7 Market Share Analysis, By Technique
5.2 Preservation Technique
5.2.1 Introduction
5.2.2 University of Wisconsin Solution (UW Solution)
5.2.3 Custodiol HTK
5.2.4 Perfadex
5.2.5 Other Preservation Solutions
5.2.6 Y-o-Y Growth Analysis, By Preservation Technique
5.2.7 Market Attractiveness Analysis, By Preservation Technique
5.2.8 Market Share Analysis, By Preservation Technique
5.3 Organ Type
5.3.1 Introduction
5.3.2 Kidneys
5.3.3 Liver
5.3.4 Lung
5.3.5 Heart
5.3.6 Other Organs (Pancreas, Intestine)
5.3.7 Y-o-Y Growth Analysis, By Organ Type
5.3.8 Market Attractiveness Analysis, By Organ Type
5.3.9 Market Share Analysis, By Organ Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technique
6.1.3.3 By Preservation Technique
6.1.3.4 By Organ Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technique
6.1.4.3 By Preservation Technique
6.1.4.4 By Organ Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technique
6.1.5.3 By Preservation Technique
6.1.5.4 By Organ Type
6.2 United States
6.3 Canada
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Waters Medical Systems LLC [Institut Georges Lopez (IGL]
8.1.1 Overview
8.1.2 Technique Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bridge to Life Limited
8.3 Organox Limited
8.4 Transmedics, Inc.
8.5 Xvivo Perfusion AB
8.6 Preservation Solutions, Inc.
8.7 Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.)
8.8 Essential Pharmaceuticals, LLC
8.9 Dr. Franz Kohler Chemie GmbH
8.10 21st Century Medicine Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
